Roivant Sciences Ltd.
ROIV
$20.81
-$0.06-0.29%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 50.68% | -334.38% | -36.63% | -96.68% | -- |
| Total Depreciation and Amortization | -51.91% | -46.41% | -40.81% | -22.87% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -64.07% | 124.86% | -167.69% | 93.89% | -- |
| Change in Net Operating Assets | -31.38% | 45.93% | 116.13% | -350.55% | -- |
| Cash from Operations | 30.41% | -5.99% | -59.11% | 1.52% | -35.83% |
| Capital Expenditure | -687.95% | -318.13% | -132.38% | -414.65% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 9,419.15% | -97.05% | -- |
| Other Investing Activities | 103.77% | -- | 12,275.68% | -- | -- |
| Cash from Investing | 103.66% | -112,409.43% | 15,405.11% | -91.32% | -8,935.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -540.71% | -- |
| Issuance of Common Stock | 850.30% | 1,223.51% | 254.88% | 216.57% | -- |
| Repurchase of Common Stock | 94.34% | 67.05% | -958.59% | -7,505.64% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 157.38% | 71.58% | -443.01% | -215.34% | -152.47% |
| Foreign Exchange rate Adjustments | -76.09% | 129.74% | 42.81% | -135.08% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.96% | -72.32% | 636.25% | -100.52% | -13,748.95% |